99 related articles for article (PubMed ID: 20164542)
1. Applicability of antibody and mRNA expression microarrays for identifying diagnostic and progression markers of early and late stage colorectal cancer.
Spisák S; Galamb B; Sipos F; Galamb O; Wichmann B; Solymosi N; Nemes B; Molnár J; Tulassay Z; Molnár B
Dis Markers; 2010; 28(1):1-14. PubMed ID: 20164542
[TBL] [Abstract][Full Text] [Related]
2. [Tissue microarray (TMA) validated progression markers in colorectal cancer using antibody microarrays].
Spisák S; Galamb B; Wichmann B; Sipos F; Galamb O; Solymosi N; Nemes B; Tulassay Z; Molnár B
Orv Hetil; 2009 Aug; 150(34):1607-13. PubMed ID: 19648079
[TBL] [Abstract][Full Text] [Related]
3. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J
Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003
[TBL] [Abstract][Full Text] [Related]
4. Potential biomarkers of colorectal adenoma-dysplasia-carcinoma progression: mRNA expression profiling and in situ protein detection on TMAs reveal 15 sequentially upregulated and 2 downregulated genes.
Galamb O; Sipos F; Spisák S; Galamb B; Krenács T; Valcz G; Tulassay Z; Molnár B
Cell Oncol; 2009; 31(1):19-29. PubMed ID: 19096147
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of gene expression by cDNA microarray in human colorectal cancer tissues and normal mucosa.
Bianchini M; Levy E; Zucchini C; Pinski V; Macagno C; De Sanctis P; Valvassori L; Carinci P; Mordoh J
Int J Oncol; 2006 Jul; 29(1):83-94. PubMed ID: 16773188
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic mRNA expression patterns of inflamed, benign, and malignant colorectal biopsy specimen and their correlation with peripheral blood results.
Galamb O; Sipos F; Solymosi N; Spisák S; Krenács T; Tóth K; Tulassay Z; Molnár B
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2835-45. PubMed ID: 18843029
[TBL] [Abstract][Full Text] [Related]
7. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.
Babel I; Barderas R; Díaz-Uriarte R; Martínez-Torrecuadrada JL; Sánchez-Carbayo M; Casal JI
Mol Cell Proteomics; 2009 Oct; 8(10):2382-95. PubMed ID: 19638618
[TBL] [Abstract][Full Text] [Related]
8. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
9. MMP3 and CXCL1 are potent stromal protein markers of dysplasia-carcinoma transition in sporadic colorectal cancer.
Sipos F; Germann TM; Wichmann B; Galamb O; Spisák S; Krenács T; Tulassay Z; Molnár B; Műzes G
Eur J Cancer Prev; 2014 Sep; 23(5):336-43. PubMed ID: 24999605
[TBL] [Abstract][Full Text] [Related]
10. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
11. Gene expression in colorectal cancer.
Birkenkamp-Demtroder K; Christensen LL; Olesen SH; Frederiksen CM; Laiho P; Aaltonen LA; Laurberg S; Sørensen FB; Hagemann R; ØRntoft TF
Cancer Res; 2002 Aug; 62(15):4352-63. PubMed ID: 12154040
[TBL] [Abstract][Full Text] [Related]
12. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.
Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR
Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796
[TBL] [Abstract][Full Text] [Related]
13. Identification of key lncRNAs in colorectal cancer progression based on associated protein-protein interaction analysis.
Zhu H; Yu J; Zhu H; Guo Y; Feng S
World J Surg Oncol; 2017 Aug; 15(1):153. PubMed ID: 28797257
[TBL] [Abstract][Full Text] [Related]
14. Identification of disrupted pathways in ulcerative colitis-related colorectal carcinoma by systematic tracking the dysregulated modules.
Wu D; Li Q; Song G; Lu J
J BUON; 2016; 21(2):366-74. PubMed ID: 27273946
[TBL] [Abstract][Full Text] [Related]
15. High-throughput proteomics integrated with gene microarray for discovery of colorectal cancer potential biomarkers.
Yu J; Li X; Zhong C; Li D; Zhai X; Hu W; Guo C; Yuan Y; Zheng S
Oncotarget; 2016 Nov; 7(46):75279-75292. PubMed ID: 27661117
[TBL] [Abstract][Full Text] [Related]
16. Identification of the TP53-induced glycolysis and apoptosis regulator in various stages of colorectal cancer patients.
Al-Khayal K; Abdulla M; Al-Obeed O; Al Kattan W; Zubaidi A; Vaali-Mohammed MA; Alsheikh A; Ahmad R
Oncol Rep; 2016 Mar; 35(3):1281-6. PubMed ID: 26675982
[TBL] [Abstract][Full Text] [Related]
17. Significant overexpression of Hsp110 gene during colorectal cancer progression.
Slaby O; Sobkova K; Svoboda M; Garajova I; Fabian P; Hrstka R; Nenutil R; Sachlova M; Kocakova I; Michalek J; Smerdova T; Knoflickova D; Vyzula R
Oncol Rep; 2009 May; 21(5):1235-41. PubMed ID: 19360299
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer.
Zieglschmid V; Hollmann C; Mannel J; Albert W; Jaeschke-Melli S; Eckstein B; Hillemann T; Greten TF; Gross E; Böcher O
Anticancer Res; 2007; 27(4A):1823-32. PubMed ID: 17649779
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of tumor necrosis factor-α is associated with advanced colorectal cancer stages.
Al Obeed OA; Alkhayal KA; Al Sheikh A; Zubaidi AM; Vaali-Mohammed MA; Boushey R; Mckerrow JH; Abdulla MH
World J Gastroenterol; 2014 Dec; 20(48):18390-6. PubMed ID: 25561807
[TBL] [Abstract][Full Text] [Related]
20. Novel evidence for a PIWI-interacting RNA (piRNA) as an oncogenic mediator of disease progression, and a potential prognostic biomarker in colorectal cancer.
Weng W; Liu N; Toiyama Y; Kusunoki M; Nagasaka T; Fujiwara T; Wei Q; Qin H; Lin H; Ma Y; Goel A
Mol Cancer; 2018 Jan; 17(1):16. PubMed ID: 29382334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
